managementceoblind-spotsrevenuepilotageb2b

CEO Revenue Blind Spots in B2B: The Complete Guide

The 10 revenue blind spots every B2B CEO faces: pipeline padding, churn masking, CAC drift, CRM theater. How to detect, measure, and neutralize them.

Charles-Alexandre Peretz21 min read

Co-founder of ACROSS INSIGHT, 15 years in Revenue Operations. Expert in B2B commercial performance diagnostics.

You run your B2B company with rigor. You track KPIs, challenge your teams, validate forecasts. And yet, quarter after quarter, one reality always ends up surfacing: a CEO revenue blind spot is an area of the sales activity where you lose visibility into the real health of the business, because the information doesn't surface, surfaces filtered, or surfaces too late to act on. These blind spots are neither accidents nor individual failures. They are the structural consequence of hierarchy, of human biases that are perfectly rational at the individual level, and of reporting tools that summarize too quickly.

Our Revenue Health Score diagnostics conducted with B2B scale-ups show that 73% of CEOs discover at least one major blind spot within the first six months of engagement, and that 41% of missed quarters trace back to a signal that already existed 60 to 90 days earlier, but that no one had surfaced. The problem is almost never a lack of data. The problem is that data flows through a system where every layer filters, rounds, and softens it. By the time it reaches the CEO, it tells a coherent, optimistic, and partially false story.

This article details the 10 most common blind spots in a B2B scale-up, explains why each one stays hidden despite seemingly solid reporting, describes the weak signals that reveal them, offers an operational antidote for each, then maps the specific vulnerabilities of the 4 non-sales CEO archetypes. The goal: to give you a usable reading grid you can apply at your next leadership team meeting.

Key Takeaways

  • A revenue blind spot is an area where the CEO loses visibility into the real health of the business: inflated pipeline, masked churn, drifting CAC, theatrical CRM, a single top performer not identified as a risk.
  • 10 classic blind spots cover 80% of cases: pipeline padding, churn masking, top performer dependency, CAC drift, CRM theater, chronic forecast optimism, hidden sales-marketing tension, undeclared client concentration, unaudited renewal pricing, unescalated product gaps.
  • Three structural causes explain why they persist: hierarchy mechanically filters information, monthly reporting smooths out weak signals, and the CRO has a self-preservation bias that filters out bad news.
  • Four CEO archetypes have different vulnerabilities: the tech/product CEO underestimates the pipeline, the finance CEO over-smooths the forecast, the ops CEO over-measures performance, the sales/marketing CEO lies to themselves about closing.
  • Four anti-blind-spot rituals are enough: a monthly skip-level, one customer call per week, a quarterly CRM spot check, and customer NPS plus raw verbatims.
  • The CEO who detects their blind spots quickly experiences more stable quarters: in our diagnostics, executives who practice at least three of these four rituals have forecast variance twice as low as the average.
  • An unaddressed blind spot doesn't disappear: it grows silently until it forces a brutal correction, often in the form of a missed quarter, an unanticipated departure, or a major client loss.

"The most important thing an entrepreneur must understand is that the information processing systems of an organization tend to filter and smooth the data, so that by the time it reaches the CEO, the bad news is gone." Andrew Grove, High Output Management

What Exactly Is a Revenue Blind Spot

A revenue blind spot is not an absence of data. It's a dissonance between the reported data and the operational reality. The pipeline shows €2.5M, but half the deals have no documented next step. NRR shows 105%, but it includes artificial renewal uplifts that mask 8 points of churn. CAC shows €18,000, but it doesn't include the cost of marketing tools or BDR compensation. Every time, the numbers exist, the dashboard is clean, the board presentation is convincing. And yet, reality tells a different story.

The reason blind spots persist despite apparent discipline is simple: they result from a chain of decisions that are individually rational. The sales rep who inflates their optimistic forecast is protecting their job. The CSM who delays reporting a churn still hopes to win the client back. The VP who rounds up numbers for the board wants to show a team under control. Each person acts in their own local interest. The cumulative effect produces a CEO who runs the business on partial data without knowing it.

Three levels of blind spots need to be distinguished. Technical blind spots stem from a tooling or process gap (a poorly configured CRM, no tracking in place). Organizational blind spots stem from a hierarchical filter (information surfaces distorted). Cultural blind spots stem from an incentive system (no one has an interest in telling the truth). All three coexist almost every time. Ignoring any one of them dooms the exercise to stay superficial.

The 10 Classic Blind Spots in a B2B Scale-Up

Here is the map of the 10 blind spots found in 80% of our diagnostics. The order is not arbitrary: it follows descending frequency and observed average severity.

Blind Spot 1: Pipeline Padding

Your CRO shows a pipeline at 3x quota. You're reassured. Yet 40% of the opportunities are zombie deals created to hit the target coverage ratio, and 25% are real deals with no documented next step, and therefore unverifiable. Pipeline padding isn't a lie, it's a commercial optimization that suits everyone: the VP Sales shows volume, the CRO shows substance, the CEO presents a pipeline that matches board expectations.

Blind Spot 2: Churn Masking

NRR shows 105%. A shiny number. What the aggregate hides: 12 points of upsell offsetting 7 points of silent churn. CSMs internally negotiate downgrades that they present as renewals. Clients who have cut their usage by 40% but still pay the same amount aren't counted as at-risk. Churn masking is the most dangerous blind spot because it makes the gradual erosion of the base invisible.

Blind Spot 3: Single Top Performer Dependency

One sales rep produces 35% of the team's revenue. Two produce 60%. The CEO knows this in the abstract but hasn't measured the exposure. If that rep leaves, negotiates a 40% raise, or gets sick, the quarter is lost. No one raises this with the board because it suits everyone: the top performer gets VIP treatment, the VP Sales has a team that looks under control, the CEO hits their number. The article top performer dependency: the silent risk details how to measure this exposure.

Blind Spot 4: CAC Drift

Your reported CAC has been stable at €18,000 for 18 months. Yet the real CAC has drifted by 22% over the period. Reasons: marketing compensation isn't included, tools have doubled, BDRs were hired but their cost is only partially allocated, and channels are gradually saturating. Marketing doesn't flag this drift because it considers it normal. Finance doesn't see it because it aggregates differently. The CEO is steering with an obsolete CAC.

Blind Spot 5: CRM Theater

Everyone uses the CRM. Deals are created, stages updated, notes added. And yet the data is largely fictional: 40% of opportunities have no realistic decision date, 35% have no identified decision-maker contact, 50% of custom fields are empty or outdated. The CRM is a theater where everyone plays their role. The forecast that comes out of it is a consensual fiction. See CRM data quality: the real cost for the reference audit.

Blind Spot 6: Chronic Forecast Optimism

Quarter after quarter, the initial forecast beats the actual by 15 to 25%. The CEO knows it, expects it, and applies a mental discount factor. But that discount masks the real signal: the team doesn't know how to predict, doesn't practice predicting, and no one is held accountable for past misses. Chronic forecast optimism isn't a bias, it's a symptom of failing sales management. A forecast within +/- 5% is achievable with discipline. The article sales forecasting: measurable precision lays out the method.

Blind Spot 7: Hidden Sales-Marketing Tension

In meetings, sales and marketing agree. Behind the scenes, they blame each other: sales says the leads are bad, marketing says the leads aren't worked properly. The CEO hears an official line that smooths everything over. Yet the MQL-SQL SLA is fuzzy, the feedback loop is broken, and 30% of marketing leads die in the CRM untouched. The hidden tension forces the CEO into a permanent arbitration whose terms they don't understand. See sales-marketing arbitration: the CEO's role.

Blind Spot 8: Undeclared Client Concentration

Three clients account for 42% of recurring revenue. The CEO thinks they account for 30%. The gap comes from the fact that concentration isn't calculated formally, or that it's calculated on signed ARR rather than collected revenue. One of these clients hits a cash crisis or changes decision-maker: the quarter is lost, fundraising is compromised, valuation is cut in half. The concentration blind spot stays invisible as long as none of the major clients moves.

Blind Spot 9: Unaudited Renewal Pricing

Renewals run on autopilot. CSMs renew contracts without touching the price. Meanwhile, the market has moved, your competitors have raised prices, your perceived value has grown. You're leaving 15 to 25% of revenue on the table every year, because no one has the mandate, skill, or incentive to audit renewal pricing. The CRO doesn't own it (renewals = CSM territory). The CSM doesn't own it (churn risk). The CFO doesn't own it (not their remit). The blind spot lives on.

Blind Spot 10: Unescalated Product Gaps Driving Churn

CSMs know that three missing features cause 40% of churn. Sales reps know that two product objections cause 25% of late-stage deals to be lost. This information doesn't reach product because the channels are broken, or because it reaches product without decision-making weight. The CEO is steering a product roadmap decoupled from revenue signals. Product priorities are sound in the abstract, wrong relative to revenue.

#Blind SpotWhy It Stays HiddenDetection Signal
1Pipeline paddingSuits everyone (CRO, VP, CEO)Pipeline/quota ratio > 3.5x without matching velocity
2Churn maskingNRR aggregate hides the erosionGRR vs NRR gap > 8 points
3Single top performerVIP treatment, not measuredTop 1 rep > 25% of team revenue
4CAC driftMarketing doesn't flag itFully-loaded CAC ≠ reported CAC
5CRM theaterClean data on the surfaceMissing next step > 30% of deals
6Forecast optimismCEO's mental discount factorForecast/actual gap > 15% over 4 quarters
7Sales-marketing tensionSmoothed official narrativeMQL-SQL SLA fuzzy or not honored
8Client concentrationNot formally calculatedTop 3 clients > 35% of ARR
9Renewal pricingNo one has the mandateRenewal price = signing price +0%
10Product gapsFeedback channels brokenChurn reasons = features x3+

Why These Blind Spots Persist: 3 Structural Causes

Blind spots aren't a lack of rigor. They are a structural consequence of how an organization functions. Three mechanisms explain why they persist.

Hierarchy Mechanically Filters Information

At every layer, the message gets filtered on its way up. The sales rep who sees a deal slip tells their manager in softened terms. The manager who summarizes three teams rounds up. The VP Sales who preps the leadership meeting optimizes. The CRO who presents to the CEO selects. This isn't deliberate lying, but a chain of small, individually reasonable roundings. Cumulated, they produce a 20 to 30% gap between what's happening on the ground and the CEO's perception.

This effect is known as filtering bias. Andrew Grove formalized it as early as the 1980s. The only effective countermeasure is systematic skip-level: the CEO bypasses their direct hierarchy to gather information two or three layers down, without going through the usual filter.

Monthly Reporting Smooths Out Weak Signals

Monthly reporting is not neutral. By construction, it aggregates, averages, and summarizes. A weak signal that appears on a Tuesday in a team of three sales reps disappears completely in the monthly summary of 15 reps. Blind spots lodge exactly where signals are weak but persistent.

The countermeasure is to complement monthly reporting with weekly rituals around leading indicators: pipeline velocity by stage, no-show rate on demos, customer sentiment on renewals in progress, lead conversion over the last 30 days. Not one more dashboard: a different reading routine.

The CRO Has a Self-Preservation Bias

Your CRO isn't dishonest. But they have a utility function that incentivizes filtering. Surfacing too much bad news exposes them. Surfacing bad news they don't know how to solve exposes them even more. The predictable result: they surface the problems they have under control and filter out the ones they don't, or the ones that could call their perceived value into question.

This bias isn't specific to your CRO. It's universal to every manager in a critical function. The only countermeasure is an informational counterweight: a source of information independent from the sales line. This can be a VP RevOps reporting to the CEO, an external diagnostic, or simply a customer call ritual that bypasses the CRO. See hiring a CRO: when and why for the related question of profile.

The Antidotes: One per Blind Spot

Each blind spot has a matching operational antidote. The goal isn't perfection, it's putting in place a simple mechanism that prevents recurrence.

Blind SpotOperational Antidote
Pipeline paddingStrict exit criteria per stage + weekly review of deals > 60 days with no next step
Churn maskingPublish GRR alongside NRR, separate renewals and upsells in reporting
Single top performerCalculate team concentration, formalize a succession plan
CAC driftFully-loaded CAC calculated quarterly by the CFO, not marketing
CRM theaterQuarterly CEO spot check on 20 random opportunities
Forecast optimismScore each sales rep on forecast accuracy, not just quota attainment
Sales-marketing tensionWritten MQL-SQL SLA, monthly review of dead leads, CEO mandate
Client concentrationMonthly calculation of top 3, top 5, top 10 as % of recurring revenue
Renewal pricingExplicit CSM mandate to audit pricing at every renewal, minimum +5% target
Product gapsFormal Sales/CSM to Product channel, monthly scoring of churn reasons

The antidote doesn't need to be sophisticated. It has to be simple, recurring, and explicitly owned by someone. An antidote without an owner disappears within 90 days.

Focus: How to Measure the Size of a Blind Spot

Identifying a blind spot is a first step. Quantifying it is essential to prioritize it. Three dimensions must be measured systematically.

Dimension 1: Annualized Revenue Impact

How much does this blind spot cost over a trailing 12 months? For pipeline padding, calculate the difference between forecasted revenue and actual revenue over the last 4 quarters. For churn masking, calculate the real GRR and compare it to the reported NRR. For CAC drift, recalculate the fully-loaded CAC and compare it to the reported CAC, then multiply by the number of clients acquired. This first measurement gives you a sense of scale.

Dimension 2: Rate of Deterioration

A stable blind spot is less urgent than one that's accelerating. Track the metric's evolution over 6 quarters. Churn masking that worsens by 2 points per quarter deserves immediate treatment. Pipeline padding that's been stable for 18 months can wait until the end of the budget cycle. Speed trumps magnitude in prioritization.

Dimension 3: Leverage Effect on Other Blind Spots

Some blind spots feed the others. CRM theater makes it impossible to detect pipeline padding, forecast optimism, and even client concentration. Fixing it first unlocks the measurement of the other three. Conversely, unaudited renewal pricing lives relatively isolated: fixing it doesn't unlock anything else. The leverage effect changes the priority.

Blind SpotAverage Annualized ImpactRate of DeteriorationLeverage Effect
Pipeline padding12-20% of forecast revenueStableMedium
Churn masking15-25% of ARRFast (accelerating)High
Single top performerVariable, 20-40% if departureDormantLow
CAC drift15-30% of marketing budgetSlow but continuousMedium
CRM theater8-15% of sales productivityStableVery high
Forecast optimism10-20% chronic gapStableHigh
Sales-marketing tension15-25% of leads lostStableMedium
Client concentrationUp to 40% if departureDormantLow
Renewal pricing10-20% of ARR/yearCumulativeLow
Product gaps20-35% of churnCumulativeMedium
Ou en est votre Management ?

Evaluez votre maturite sur les 8 piliers en 2 minutes. Score instantane, gratuit.

Faire le quiz gratuit →

How to Detect a Blind Spot You Don't Suspect

The most dangerous trap isn't the blind spot you've identified but haven't treated. It's the one you don't suspect at all. Three methods can flush them out.

The Gap Method

Systematically compare what the official reporting says to what the raw sources say. The CRM pipeline vs. the real pipeline (20 opportunities audited by hand). Published NRR vs. GRR calculated by cohort. Reported CAC vs. recalculated fully-loaded CAC. The gaps are the signal. A systematic gap between two measurements of the same reality is the signature of a blind spot.

The Verbatims Method

Organize 5 customer calls per month (beyond sales calls), listening without preparing a pitch. Customers spontaneously say what internal reporting doesn't. Verbatims are the richest raw material for detecting product, pricing, and customer experience blind spots. Our diagnostics systematically include 10 to 15 customer interviews for this reason.

The Unexplained Exits Method

Track every client departure, every sales rep departure, every deal lost late in the cycle. The stated reasons are rarely the real reasons. A pattern that emerges across 10 cases reveals a blind spot. For example: "clients who leave at 18 months all requested feature X, which was never prioritized" is an actionable data point.

The 4 CEO Archetypes and Their Specific Blind Spots

Not all CEOs have the same blind spots. The founding archetype dictates the priority blind zones.

Archetype 1: The Tech/Product CEO

The tech CEO believes the product sells itself. Their primary blind spot is pipeline padding: they trust the CRO to judge pipeline quality, because they lack the expertise to challenge the numbers. They also underestimate CAC drift, because they see marketing as a cost center rather than an acquisition engineering function.

Archetype 2: The Finance/Investor CEO

The finance CEO wants to predict everything. Their primary blind spot is forecast optimism: they accept a stable mental discount factor quarter after quarter without challenging its cause. They are also vulnerable to CRM theater, because they read dashboards without auditing the inputs. Their biggest blind spot: hidden sales-marketing tension, which they don't see because the numbers smooth everything over.

Archetype 3: The Ops/Consulting CEO

The ops CEO over-measures performance. Their primary blind spot is unaudited renewal pricing: they set up sophisticated reporting processes but never put anyone in charge of pricing. They are also vulnerable to churn masking, because their dashboards aggregate data to look clean, at the expense of weak signals.

Archetype 4: The Sales/Marketing CEO

Paradoxically, the CEO who came up through sales has blind spots too. Their primary blind spot is single top performer dependency: they downplay the risk because they trust their own ability to "always find another sales rep." They are also vulnerable to undeclared client concentration, because they overvalue their relationships with top accounts.

ArchetypePrimary Blind SpotSecondary Blind SpotAggravating Factor
Tech/ProductPipeline paddingCAC driftNo expertise to challenge
FinanceForecast optimismSales-marketing tensionTrust in the numbers
Ops/ConsultingUnaudited renewal pricingChurn maskingProcess over ground truth
Sales/MarketingSingle top performerClient concentrationTrust in relationships

The 4 Anti-Blind-Spot Rituals

The good news: four simple rituals are enough to detect 80% of blind spots before they become critical. They don't replace reporting, they complement it.

Ritual 1: Monthly Skip-Level

One hour a month, the CEO meets individually with three people two levels down in the revenue organization: a senior sales rep, a CSM, a RevOps person. No CRO in the room. No formal agenda. Open questions. The goal isn't to control, it's to gather the information that doesn't make it to the top. This ritual alone surfaces 30% of potential blind spots.

Ritual 2: One Customer Call per Week

52 customer calls a year, outside of sales calls. Active customers, churned customers, lost prospects. Listen. Don't pitch. Take notes. After 20 calls, patterns emerge around pricing, product, competitors, experience. These patterns are the richest source for detecting unsuspected blind spots.

Ritual 3: Quarterly CRM Spot Check

Every quarter, the CEO randomly pulls 20 opportunities from the CRM and audits them: next step, decision date, decision-maker contact, last activity. The simple fact that this ritual exists changes CRM discipline across the whole team. It also immediately reveals the extent of CRM theater.

Ritual 4: Customer NPS with Raw Verbatims

A quarterly NPS with open verbatims, read directly by the CEO. Not the average NPS, the verbatims one by one. The 20 best and the 20 worst. This ritual takes two hours and surfaces more signals than three months of aggregated CSM reporting. It detects churn masking and product gaps.

RitualFrequencyTimeBlind Spots Detected
Skip-levelMonthly1hFiltering, hidden tension, real pipeline
Customer callWeekly30 minChurn, pricing, product, experience
CRM spot checkQuarterly2hCRM theater, pipeline padding
NPS + verbatimsQuarterly2hChurn masking, product gaps

Early Warning Signs: The 6 Signals That Should Trigger an Alert

Before a blind spot becomes critical, it almost always sends signals. Six recurring signals should trigger an immediate investigation.

First signal: a forecast that tells itself the same story four quarters in a row. "Q4 will catch up." "The big deals close at year-end." "The pipeline is building for next quarter." This repetition isn't bad luck, it's an entrenched bias.

Second signal: a sales team that stops losing deals. A win rate that climbs with no clear explanation is often the symptom of qualification that has quietly tightened, not of improving performance. The CRO hides losses by refusing to create opportunities that could be lost.

Third signal: renewals that happen without any negotiation. If your CSM team hasn't had a tense pricing conversation in six months, it's because no one dares raise it. The renewal pricing blind spot lives on.

Fourth signal: a clean CRM but deals that keep slipping. A classic discrepancy. Sales reps document to follow the process, not to reflect reality. CRM theater has taken hold.

Fifth signal: a CRO who downplays bad news before you even ask the question. A subtle phenomenon: they anticipate your reaction and defuse it before you dig deeper. The filtering bias is systemic.

Sixth signal: a sales team that no longer challenges you in meetings. A healthy sales org argues, defends its turf, contests the numbers. An anesthetized sales org rubber-stamps everything. The absence of friction is a more reliable red flag than friction itself.

What the ACROSS Patterns Show

Our Revenue Health Score diagnostics surface two categories of CEOs: those who detect their blind spots in under six months, and those who discover them during a missed quarter or an external audit.

CEOs who detect quickly share three traits. First, they regularly practice at least three of the four anti-blind-spot rituals. Second, they have an internal informational counterweight (VP RevOps, COO, or an active board member). Third, they have publicly admitted at least once to being wrong about a number, which creates a climate where bad news travels faster.

CEOs who detect late also share common traits. They over-delegate revenue to the CRO without any guardrails. They prefer dashboards to on-the-ground conversations. They have no systematic customer contact ritual. And they have a board that challenges them on results, but not on the quality of the machine. The predictable consequence: a brutal discovery, often during a fundraise or a missed quarter.

The most discriminating factor isn't the CEO's intelligence, nor their experience, nor the quality of their CRO. It's the presence or absence of a systemic informational counterweight. A CEO alone facing their CRO always ends up developing blind spots, no matter how rigorous they are. A CEO who has built three or four independent information sources detects fast, corrects early, and experiences more stable quarters.

Template: Revenue Blind Spot Self-Audit Grid

Here is a grid you can use this week. 10 questions, 10 blind spots, an overall score in 30 minutes.

#QuestionYes Answer = Low RiskNo Answer = High Risk
1I know the rate of deals with no next step > 60 daysYes / NoAudit recommended
2I read GRR separately from NRR every quarterYes / NoAdd to reporting
3I know the % of revenue from my top repYes / NoCalculate immediately
4My CAC is calculated fully-loaded by the CFOYes / NoRecalculate quarterly
5I've audited 20 CRM opportunities this quarterYes / NoNext spot check
6My forecast accuracy is tracked per repYes / NoSet up the metric
7My MQL-SQL SLA is written and reviewed monthlyYes / NoFormalize it
8I know the % of ARR from my top 3 clients this monthYes / NoCalculate immediately
9My renewals have a minimum +5% pricing targetYes / NoCSM mandate
10I read churn verbatims every quarterYes / NoNPS ritual

Score: Count your "yes" answers. 9-10 yes: healthy machine, keep up the discipline. 6-8 yes: several likely blind spots, prioritize 2 or 3 for the quarter. 3-5 yes: high risk, an external audit is justified. 0-2 yes: your steering relies on fictional data, act immediately.

FAQ: CEO Revenue Blind Spots

How many blind spots does a typical B2B scale-up have?

In our diagnostics, the average is 4 to 6 critical blind spots (impact > 10% of annual revenue) and 8 to 12 secondary ones. No scale-up has zero. The most common ones affect the pipeline (padding, quality), retention (NRR vs. GRR), and go-to-market (fully-loaded CAC). A structured audit detects 80% of them in six to eight weeks.

Which blind spot is the most costly on average?

Churn masking comes out on top with 15 to 25% of annual revenue at risk, because it erodes the base progressively and becomes irreversible past a certain threshold. Pipeline padding follows (15 to 20%), because it distorts every investment decision. Unaudited renewal pricing can cost 20% annually but is quick to fix. See silent NRR erosion: the risk for the in-depth analysis.

How do I detect a blind spot I don't suspect?

Three methods. The gap method (comparing two measurements of the same reality and spotting divergences). The verbatims method (5 customer calls a month with no pitch). The unexplained exits method (patterns across client and sales rep departures). The three combined cover 90% of unsuspected blind spots.

How often should you audit your blind spots?

A full audit at least once a year, with quarterly checkpoints on the 3-5 blind spots identified as priorities. Hyper-growth scale-ups (ARR > 100% YoY) should audit twice a year because the machine evolves too fast. The anti-blind-spot rituals run continuously; the audit serves to complement them.

My CRO is senior and experienced. Do I still need a counterweight?

Yes, precisely because they're senior. A senior CRO performs well but has a more sophisticated self-preservation bias than a junior one. They surface the problems they have under control and filter out the ones that threaten their perceived value. The counterweight isn't a sign of distrust, it's a structural discipline. The best CROs ask for an independent RevOps themselves, because they know it makes them better.

Can a CEO detect all their blind spots alone?

No. It's mathematical: a CEO can't be their own independent source of information. They need at least one source that sits outside their direct hierarchy. An active board member, a VP RevOps reporting to them, an external diagnostic, a revenue coach. Without an external source, they only detect the blind spots their hierarchy agrees to surface.

Which blind spot should I address first if I discover several?

The one with the highest revenue impact multiplied by the rate of deterioration. Pipeline padding that costs 20% but stays stable is less urgent than churn masking that costs 12% but is accelerating. See revenue red flags: operational detection for the prioritization method.

How do I convince my leadership team we have blind spots without creating panic?

Present a factual data point, not an opinion. Start with a single blind spot that's easy to measure (for example: forecast accuracy over a trailing 12 months). Calculate its cost in lost revenue. Propose a 90-day plan with two or three quick wins. Once the first one is successfully addressed, the leadership team will agree to audit the others. Panic always comes from the absence of a plan, not from identification.

Can blind spots be eliminated completely?

No. Your company will always evolve faster than your measurement systems. The realistic goal is to keep critical blind spots (impact > 10% of revenue) at zero, and to build a culture and rituals that detect new blind spots within 60 days of their appearance. The CEO who knows what they don't know isn't chasing omniscience, they're chasing fast visibility.

Additional Resources

Cited Sources

  • Andrew Grove, High Output Management, Vintage Books, 1995 (information filtering in hierarchical organizations)
  • ACROSS Revenue Health Score diagnostics, French and European B2B scale-ups analyzed between 2023 and 2026
  • Gartner, CEO and Senior Business Executive Survey 2025, Sales Performance section
  • Bessemer Venture Partners, State of the Cloud 2024, segmented NRR vs. GRR analysis

Article written by Charles-Alexandre Peretz, founder of ACROSS Insight, based on our Revenue Health Score diagnostics conducted with B2B scale-ups. Last updated: July 23, 2026.

Move from intuition to certainty.

A complete diagnostic in 2 weeks. A 90-day action plan. Measurable results.

Schedule a call